Lawrence, KS, United States of America

Chad Schroeder


Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Chad Schroeder: Innovator in Quinazolinone Inhibitors

Introduction

Chad Schroeder is a notable inventor based in Lawrence, Kansas, with a focus on developing innovative compounds for medical applications. He holds a total of seven patents, showcasing his contributions to the field of pharmaceutical chemistry.

Latest Patents

Among his latest patents are the 6-substituted quinazolinone inhibitors. This technology relates to compounds and compositions of Formulas I-III, which are designed for use in the treatment or prophylaxis of diseases associated with alphaviruses, such as the Venezuelan equine encephalitis virus (VEEV). The significance of these compounds lies in their potential to address serious viral infections.

Career Highlights

Chad has had a distinguished career, working with reputable institutions such as the University of Kansas. His research and development efforts have contributed significantly to advancements in medical treatments, particularly in the realm of viral diseases.

Collaborations

Throughout his career, Chad has collaborated with esteemed colleagues, including Jennifer Elizabeth Golden and Jeffrey Aube. These partnerships have enhanced his research capabilities and have led to the successful development of his patented technologies.

Conclusion

Chad Schroeder's work in the field of quinazolinone inhibitors exemplifies the impact of innovative research on public health. His contributions through patents and collaborations continue to pave the way for advancements in

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…